Replies to post #173908 on Vivos Inc (RDGL)

[wrinklesobw]

I hope so too, If you have enough shares hold onto even a small amount if you can for a year or two or more and I do believe we will be on the NASDAQ and sitting at $25 plus a share.

Remember human trials will only last 12-18 months, if approved Mayo Clinic will be our first customer with future purchases.

Then the second indication ide application will be submitted. Have no idea what the second application will be. If that gets approved then they will apply for a wide spread use for the rest of the types of cancers to be treated.

So in roughly about 4-5yrs this coupe fully approved for all 18 cancers that they have indicated use for.

Then don’t forget about isopet, hopefully by then it will be a million plus revenue maker by then.

Then also anything everything to do with the overseas market, which I believe once thyroid is approved they will start the process of getting it approved across the pond’s.

All my opinion of course, and yes a buyout and or partnership is very possible.

[nathanial]

But that is going well beyond your 18.73% rule?

[Gobsmacked01]

I am not implying anything and past performance is NO indication of future price per share... but having said that have you checked out their chart for the Q1/Q2 time frame in 2012? There was a previous FDA submission that was waaaay unsupported compared to data available this time around. Where did the pps go back then?

-Go $RDGL